FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1882-1890 December 16, 1999 Number 25 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

ABSTRACT

Background Empirical antiarrhythmic therapy has not reduced mortality among patients with coronary artery disease and asymptomatic ventricular arrhythmias. Previous studies have suggested that antiarrhythmic therapy guided by electrophysiologic testing might reduce the risk of sudden death.

Methods We conducted a randomized, controlled trial to test the hypothesis that electrophysiologically guided antiarrhythmic therapy would reduce the risk of sudden death among patients with coronary artery disease, a left ventricular ejection fraction of 40 percent or less, and asymptomatic, unsustained ventricular tachycardia. Patients in whom sustained ventricular tachyarrhythmias were induced by programmed stimulation were randomly assigned to receive either antiarrhythmic therapy, including drugs and implantable defibrillators, as indicated by the results of electrophysiologic testing, or no antiarrhythmic therapy. Angiotensin-converting–enzyme inhibitors and beta-adrenergic–blocking agents were administered if the patients could tolerate them.

Results A total of 704 patients with inducible, sustained ventricular tachyarrhythmias were randomly assigned to treatment groups. Five-year Kaplan–Meier estimates of the incidence of the primary end point of cardiac arrest or death from arrhythmia were 25 percent among those receiving electrophysiologically guided therapy and 32 percent among the patients assigned to no antiarrhythmic therapy (relative risk, 0.73; 95 percent confidence interval, 0.53 to 0.99), representing a reduction in risk of 27 percent. The five-year estimates of overall mortality were 42 percent and 48 percent, respectively (relative risk, 0.80; 95 percent confidence interval, 0.64 to 1.01). The risk of cardiac arrest or death from arrhythmia among the patients who received treatment with defibrillators was significantly lower than that among the patients discharged without receiving defibrillator treatment (relative risk, 0.24; 95 percent confidence interval, 0.13 to 0.45; P<0.001). Neither the rate of cardiac arrest or death from arrhythmia nor the overall mortality rate was lower among the patients assigned to electrophysiologically guided therapy and treated with antiarrhythmic drugs than among the patients assigned to no antiarrhythmic therapy.

Conclusions Electrophysiologically guided antiarrhythmic therapy with implantable defibrillators, but not with antiarrhythmic drugs, reduces the risk of sudden death in high-risk patients with coronary disease.

Source Information

From the Department of Medicine, Brown University School of Medicine and Rhode Island Hospital, Providence (A.E.B.); Duke University Clinical Research Institute, Durham, N.C. (K.L.L., G.H.); the Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, N.Y. (J.D.F.); the Department of Medicine, Beth Israel Deaconess Medical Center, Boston (M.E.J.); and Care Group, Indianapolis (E.N.P.).

Address reprint requests to Dr. Buxton at the Division of Cardiology, Rhode Island Hospital, 2 Dudley St., Suite 360, Providence, RI 02905.

Full Text of this Article

Related Letters:

Prevention of Sudden Death in Patients with Coronary Artery Disease
Aggarwal A., Bloom J. M., Buxton A. E., Lee K. L.
Extract | Full Text  
N Engl J Med 2000; 342:1291-1292, Apr 27, 2000. Correspondence

This article has been cited by other articles:

• de Bie, M. K., van Dam, B., Gaasbeek, A., van Buren, M., van Erven, L., Bax, J. J., Schalij, M. J., Rabelink, T. J., Jukema, J. W. (2009). The current status of interventions aiming at reducing sudden cardiac death in dialysis patients. Eur Heart J 30: 1559-1564 [Abstract] [Full Text]  
• Task force members, , Vijgen, J., Botto, G., Camm, J., Hoijer, C.-J., Jung, W., Le Heuzey, J.-Y., Lubinski, A., Norekval, T. M., Santomauro, M., Schalij, M., Schmid, J.-P., Vardas, P. (2009). Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace 0: eup112v1-eup112 [Abstract] [Full Text]  
• Cevik, C., Perez-Verdia, A., Nugent, K. (2009). Implantable cardioverter defibrillators and their role in heart failure progression. Europace 11: 710-715 [Abstract] [Full Text]  
• Tsai, V. W., Cooper, J., Garan, H., Natale, A., Ptaszek, L. M., Ellinor, P. T., Hickey, K., Downey, R., Zei, P., Hsia, H., Wang, P., Hunt, S., Haddad, F., Al-Ahmad, A. (2009). The Efficacy of Implantable Cardioverter-Defibrillators in Heart Transplant Recipients: Results From a Multicenter Registry. Circ Heart Fail 2: 197-201 [Abstract] [Full Text]  
• Curtis, J. P., Luebbert, J. J., Wang, Y., Rathore, S. S., Chen, J., Heidenreich, P. A., Hammill, S. C., Lampert, R. I., Krumholz, H. M. (2009). Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-Defibrillator. JAMA 301: 1661-1670 [Abstract] [Full Text]  
• Gulizia, M. M., Piraino, L., Scherillo, M., Puntrello, C., Vasco, C., Scianaro, M. C., Mascia, F., Pensabene, O., Giglia, S., Chiaranda, G., Vaccaro, I., Mangiameli, S., Corrao, D., Santi, E., Grammatico, A., on behalf of PITAGORA ICD Study Investigators, (2009). A Randomized Study to Compare Ramp Versus Burst Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: The PITAGORA ICD Trial. Circ Arrhythmia Electrophysiol 2: 146-153 [Abstract] [Full Text]  
• Baman, T. S., Gupta, S. K., Valle, J. A., Yamada, E. (2009). Risk Factors for Mortality in Patients With Cardiac Device-Related Infection. Circ Arrhythmia Electrophysiol 2: 129-134 [Abstract] [Full Text]  
• Santini, M., Russo, M., Botto, G., Lunati, M., Proclemer, A., Schmidt, B., Erdogan, A., Helmling, E., Rauhe, W., Desaga, M., Santi, E., Messier, M., Boriani, G. (2009). Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace 11: 476-482 [Abstract] [Full Text]  
• Proclemer, A., Ghidina, M., Gregori, D., Facchin, D., Rebellato, L., Fioretti, P., Brignole, M. (2009). Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. Europace 11: 465-475 [Abstract] [Full Text]  
• Wilkoff, B. L., Kudenchuk, P. J., Buxton, A. E., Sharma, A., Cook, J. R., Bhandari, A. K., Biehl, M., Tomassoni, G., Leonen, A., Klevan, L. R., Hallstrom, A. P., for the DAVID II Investigators, (2009). The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial.. J Am Coll Cardiol 53: 872-880 [Abstract] [Full Text]  
• Peterson, P. N., Daugherty, S. L., Wang, Y., Vidaillet, H. J., Heidenreich, P. A., Curtis, J. P., Masoudi, F. A., on behalf of the National Cardiovascular Data Regi, (2009). Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy. Circulation 119: 1078-1084 [Abstract] [Full Text]  
• Bauer, A., Barthel, P., Schneider, R., Ulm, K., Muller, A., Joeinig, A., Stich, R., Kiviniemi, A., Hnatkova, K., Huikuri, H., Schomig, A., Malik, M., Schmidt, G. (2009). Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J 30: 576-583 [Abstract] [Full Text]  
• Stone, M. E., Apinis, A. (2009). Current Perioperative Management of the Patient With a Cardiac Rhythm Management Device. SEMIN CARDIOTHORAC VASC ANESTH 13: 31-43 [Abstract]  
• Kim, E. S.H., Menon, V. (2009). Status of Women in Cardiovascular Clinical Trials. Arterioscler. Thromb. Vasc. Bio. 29: 279-283 [Full Text]  
• Koplan, B. A., Stevenson, W. G. (2009). Ventricular Tachycardia and Sudden Cardiac Death. Mayo Clin Proc. 84: 289-297 [Abstract] [Full Text]  
• Costantini, O., Hohnloser, S. H., Kirk, M. M., Lerman, B. B., Baker, J. H. II, Sethuraman, B., Dettmer, M. M., Rosenbaum, D. S., for the ABCD Trial Investigators, (2009). The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.. J Am Coll Cardiol 53: 471-479 [Abstract] [Full Text]  
• Feld, G. K., Clopton, P. (2009). Comparability of noninvasive microvolt T-wave alternans versus invasive ventricular programmed stimulation to guide implantable cardioverter-defibrillator implantation in patients at risk of sudden death.. J Am Coll Cardiol 53: 480-482 [Full Text]  
• Nazarian, S., Bluemke, D. A., Halperin, H. R. (2009). Applications of Cardiac Magnetic Resonance in Electrophysiology. Circ Arrhythmia Electrophysiol 2: 63-71 [Full Text]  
• Donahue, J. K. (2009). Novel Strategy to Reduce Sudden-Death Risk in the Healing Phase After Myocardial Infarction. Circulation 119: 6-8 [Full Text]  
• Authors/Task Force Members, , Van de Werf, F., Bax, J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., Falk, V., Filippatos, G., Fox, K., Huber, K., Kastrati, A., Rosengren, A., Steg, P. G., Tubaro, M., Verheugt, F., Weidinger, F., Weis, M., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Silber, S., Aguirre, F. V., Al-Attar, N., Alegria, E., Andreotti, F., Benzer, W., Breithardt, O., Danchin, N., Mario, C. D., Dudek, D., Gulba, D., Halvorsen, S., Kaufmann, P., Kornowski, R., Lip, G. Y. H., Rutten, F. (2008). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:. Eur Heart J 29: 2909-2945 [Full Text]  
• Myerburg, R. J. (2008). Implantable Cardioverter-Defibrillators after Myocardial Infarction. NEJM 359: 2245-2253 [Full Text]  
• Chow, T., Kereiakes, D. J., Onufer, J., Woelfel, A., Gursoy, S., Peterson, B. J., Brown, M. L., Pu, W., Benditt, D. G., on behalf of the MASTER Trial Investigators, (2008). Does Microvolt T-Wave Alternans Testing Predict Ventricular Tachyarrhythmias in Patients With Ischemic Cardiomyopathy and Prophylactic Defibrillators?: The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) Trial. J Am Coll Cardiol 52: 1607-1615 [Abstract] [Full Text]  
• Rosenbaum, D. S. (2008). T-Wave Alternans in the Sudden Cardiac Death in Heart Failure Trial Population: Signal or Noise?. Circulation 118: 2015-2018 [Full Text]  
• Gold, M. R., Ip, J. H., Costantini, O., Poole, J. E., McNulty, S., Mark, D. B., Lee, K. L., Bardy, G. H. (2008). Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction: Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy. Circulation 118: 2022-2028 [Abstract] [Full Text]  
• Piccini, J. P., Horton, J. R., Shaw, L. K., Al-Khatib, S. M., Lee, K. L., Iskandrian, A. E., Borges-Neto, S. (2008). Single-Photon Emission Computed Tomography Myocardial Perfusion Defects Are Associated With an Increased Risk of All-Cause Death, Cardiovascular Death, and Sudden Cardiac Death. Circ Cardiovasc Imaging 1: 180-188 [Abstract] [Full Text]  
• Biffi, M., Ziacchi, M., Bertini, M., Sangiorgi, D., Corsini, D., Martignani, C., Diemberger, I., Boriani, G. (2008). Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 10: 1288-1295 [Abstract] [Full Text]  
• Pellegrini, C. N., Lee, K., Olgin, J. E., Turakhia, M. P., Tseng, Z. H., Lee, R., Badhwar, N., Lee, B., Varosy, P. D. (2008). Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace 10: 1296-1301 [Abstract] [Full Text]  
• Triedman, J. K. (2008). Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?: Implantable Cardioverter Defibrillator Implantation Guidelines Based Solely on Left Ventricular Ejection Fraction Do Not Apply to Adults With Congenital Heart Disease. Circ Arrhythmia Electrophysiol 1: 307-316 [Full Text]  
• Authors/Task Force Members, , Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Tendera, M., Auricchio, A., Bax, J., Bohm, M., Corra, U., della Bella, P., Elliott, P. M., Follath, F., Gheorghiade, M., Hasin, Y., Hernborg, A., Jaarsma, T., Komajda, M., Kornowski, R., Piepoli, M., Prendergast, B., Tavazzi, L., Vachiery, J.-L., Verheugt, F. W. A., Zamorano, J. L., Zannad, F. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29: 2388-2442 [Full Text]  
• Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989 [Full Text]  
• de Sousa, M. R., Morillo, C. A., Rabelo, F. T., Filho, A. M. N., Ribeiro, A. L.P. (2008). Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: A meta-analysis. Eur J Heart Fail 10: 1007-1014 [Abstract] [Full Text]  
• Sherazi, S., Daubert, J. P., Block, R. C., Jeevanantham, V., Abdel-Gadir, K., DiSalle, M. R., Haley, J. M., Shah, A. H. (2008). Physicians' Preferences and Attitudes About End-of-Life Care in Patients With an Implantable Cardioverter-Defibrillator. Mayo Clin Proc. 83: 1139-1141 [Abstract] [Full Text]  
• Tung, R., Zimetbaum, P., Josephson, M. E. (2008). A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death. J Am Coll Cardiol 52: 1111-1121 [Abstract] [Full Text]  
• Goldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., Stevenson, W. G., Zipes, D. P. (2008). American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 52: 1179-1199 [Full Text]  
• Goldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., Stevenson, W. G., Zipes, D. P. (2008). American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 118: 1497-1518 [Full Text]  
• Dorian, P., Al-Khalidi, H. R., Hohnloser, S. H., Brum, J. M., Dunnmon, P. M., Pratt, C. M., Holroyde, M. J., Kowey, P., on behalf of the SHIELD (SHock Inhibition Evaluati, (2008). Azimilide Reduces Emergency Department Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical Trial. J Am Coll Cardiol 52: 1076-1083 [Abstract] [Full Text]  
• Ding, L., Hua, W., Niu, H., Chen, K., Zhang, S. (2008). Primary prevention of sudden cardiac death using implantable cardioverter defibrillators. Europace 10: 1034-1041 [Abstract] [Full Text]  
• Mukaddirov, M., Demaria, R. G., Perrault, L. P., Frapier, J.-M., Albat, B. (2008). Reconstructive surgery of postinfarction left ventricular aneurysms: techniques and unsolved problems.. Eur. J. Cardiothorac. Surg. 34: 256-261 [Abstract] [Full Text]  
• Jansen, A., Mischi, M., Bracke, F., van Dantzig, J. m., Peels, K., Lamfers, E., van Hemel, N., Korsten, H. (2008). Novel ultrasound contrast agent dilution method for the assessment of ventricular ejection fraction. Eur J Echocardiogr 9: 489-493 [Abstract] [Full Text]  
• Sasano, T., Abraham, M. R., Chang, K.-C., Ashikaga, H., Mills, K. J., Holt, D. P., Hilton, J., Nekolla, S. G., Dong, J., Lardo, A. C., Halperin, H., Dannals, R. F., Marban, E., Bengel, F. M. (2008). Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction.. J Am Coll Cardiol 51: 2266-2275 [Abstract] [Full Text]  
• Scheinman, M. M., Keung, E. (2008). The Year in Review of Clinical Cardiac Electrophysiology. J Am Coll Cardiol 51: 2075-2081 [Full Text]  
• Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N.A. M. III, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51: e1-e62 [Full Text]  
• Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Mark Estes, N.A. III, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51: 2085-2105 [Full Text]  
• Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N.A. M. III, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117: 2820-2840 [Full Text]  
• Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N.A. M. III, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117: e350-e408 [Full Text]  
• Almendral, J., Arribas, F., Wolpert, C., Ricci, R., Adragao, P., Cobo, E., Navarro, X., Quesada, A., the DATAS Steering Committee and Writing Committee, (2008). Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. Europace 10: 528-535 [Abstract] [Full Text]  
• Gibson, D. P., Kuntz, K. K., Levenson, J. L., Ellenbogen, K. A. (2008). Decision-making, emotional distress, and quality of life in patients affected by the recall of their implantable cardioverter defibrillator. Europace 10: 540-544 [Abstract] [Full Text]  
• Berul, C. I., Van Hare, G. F., Kertesz, N. J., Dubin, A. M., Cecchin, F., Collins, K. K., Cannon, B. C., Alexander, M. E., Triedman, J. K., Walsh, E. P., Friedman, R. A. (2008). Results of a Multicenter Retrospective Implantable Cardioverter-Defibrillator Registry of Pediatric and Congenital Heart Disease Patients. J Am Coll Cardiol 51: 1685-1691 [Abstract] [Full Text]  
• Koller, M. T., Schaer, B., Wolbers, M., Sticherling, C., Bucher, H. C., Osswald, S. (2008). Death Without Prior Appropriate Implantable Cardioverter-Defibrillator Therapy: A Competing Risk Study. Circulation 117: 1918-1926 [Abstract] [Full Text]  
• Daubert, J. P., Zareba, W., Cannom, D. S., McNitt, S., Rosero, S. Z., Wang, P., Schuger, C., Steinberg, J. S., Higgins, S. L., Wilber, D. J., Klein, H., Andrews, M. L., Hall, W. J., Moss, A. J., for the MADIT II Investigators, (2008). Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II: Frequency, Mechanisms, Predictors, and Survival Impact. J Am Coll Cardiol 51: 1357-1365 [Abstract] [Full Text]  
• Albert, N. M., Lewis, C. (2008). Recognizing and Managing Asymptomatic Left Ventricular Dysfunction: After Myocardial Infarction. Crit Care Nurse 28: 20-37 [Full Text]  
• Wellens, H. J. (2008). Forty Years of Invasive Clinical Electrophysiology: 1967-2007. Circ Arrhythmia Electrophysiol 1: 49-53 [Full Text]  
• Elgarhi, N, Kreuz, J, Balta, O, Nickenig, G, Hoium, H, Lewalter, T, Schwab, J O. (2008). Significance of Wedensky Modulation testing in the evaluation of non-invasive risk stratification for ventricular tachyarrhythmia in patients with coronary artery disease and implantable cardioverter-defibrillator. Heart 94: e16-e16 [Abstract] [Full Text]  
• Scott, P.A., Gorman, S., Andrews, N.P., Roberts, P.R., Kalra, P.R. (2008). Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006). Europace 10: 453-457 [Abstract] [Full Text]  
• Gardiwal, A., Yu, H., Oswald, H., Luesebrink, U., Ludwig, A., Pichlmaier, A. M., Drexler, H., Klein, G. (2008). Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator. Europace 10: 358-363 [Abstract] [Full Text]  
• Travin, M. I. (2008). A Potential Key Role for Radionuclide Imaging in the Prediction and Prevention of Sudden Arrhythmic Cardiac Death. JNM 49: 173-175 [Full Text]  
• DeMaria, A. N., Bax, J. J., Ben-Yehuda, O., Clopton, P., Feld, G. K., Ginsburg, G. S., Greenberg, B. H., Knoke, J. D., Lew, W. Y.W., Lima, J. A.C., Maisel, A. S., Narayan, S. M., Narula, J., Sahn, D. J., Tsimikas, S. (2008). Highlights of the year in JACC 2007.. J Am Coll Cardiol 51: 490-512 [Full Text]  
• Goldenberg, I., Vyas, A. K., Hall, W. J., Moss, A. J., Wang, H., He, H., Zareba, W., McNitt, S., Andrews, M. L., for the MADIT-II Investigators, (2008). Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction. J Am Coll Cardiol 51: 288-296 [Abstract] [Full Text]  
• Mittal, S. (2008). Selecting Patients for an Implantable Cardioverter-Defibrillator: Can the Genie Be Put Back Into the Bottle?. J Am Coll Cardiol 51: 297-299 [Full Text]  
• Anstadt, M. P., Lowe, J. E. (2008). Cardiopulmonary Resuscitation. Card Surg Adult 3: 487-506 [Full Text]  
• Spotnitz, H. M. (2008). Surgical Implantation of Pacemakers and Automatic Defibrillators. Card Surg Adult 3: 1395-1428 [Full Text]  
• Kuhne, M., Schaer, B., Moulay, N., Sticherling, C., Osswald, S. (2007). Holter monitoring for syncope: diagnostic yield in different patient groups and impact on device implantation. QJM 100: 771-777 [Abstract] [Full Text]  
• Sutton, R., Fisher, J. D., Linde, C., Benditt, D. G. (2007). History of electrical therapy for the heart. Eur Heart J Suppl 9: I3-I10 [Abstract] [Full Text]  
• Rossenbacker, T., Priori, S. G., Zipes, D. P. (2007). The fight against sudden cardiac death: consensus guidelines as a reference. Eur Heart J Suppl 9: I50-I58 [Abstract] [Full Text]  
• Jung, W., Schumacher, B. (2007). What is the role of risk stratification for sudden death in the defibrillator era?. Eur Heart J Suppl 9: I59-I65 [Abstract] [Full Text]  
• Bansch, D., Kottkamp, H., Gronefeld, G., Vogt, J., Israel, C., Bocker, D., Hindricks, G., Kuck, K.-H., on behalf of the Quick-ICD investigators, (2007). The quick-implantable-defibrillator trial. Europace 9: 1144-1150 [Abstract] [Full Text]  
• Santini, M., Lavalle, C., Ricci, R. P. (2007). Primary and secondary prevention of sudden cardiac death: who should get an ICD?. Heart 93: 1478-1483 [Full Text]  
• Hernandez, A. F., Fonarow, G. C., Liang, L., Al-Khatib, S. M., Curtis, L. H., LaBresh, K. A., Yancy, C. W., Albert, N. M., Peterson, E. D. (2007). Sex and Racial Differences in the Use of Implantable Cardioverter-Defibrillators Among Patients Hospitalized With Heart Failure. JAMA 298: 1525-1532 [Abstract] [Full Text]  
• Authors/Task Force Members, , Vardas, P. E., Auricchio, A., Blanc, J.-J., Daubert, J.-C., Drexler, H., Ector, H., Gasparini, M., Linde, C., Morgado, F. B., Oto, A., Sutton, R., Trusz-Gluza, M., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Funck-Brentano, C., Filippatos, G., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Priori, S. G., Blomstrom-Lundqvist, C., Brignole, M., Terradellas, J. B., Camm, J., Castellano, P., Cleland, J., Farre, J., Fromer, M., Le Heuzey, J.-Y., Lip, G. Y., Merino, J. L., Montenero, A. S., Ritter, P., Schalij, M. J., Stellbrink, C. (2007). Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Europace 9: 959-998 [Full Text]  
• Vassallo, P., Trohman, R. G. (2007). Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications. JAMA 298: 1312-1322 [Abstract] [Full Text]  
• Buxton, A. E., Lee, K. L., Hafley, G. E., Pires, L. A., Fisher, J. D., Gold, M. R., Josephson, M. E., Lehmann, M. H., Prystowsky, E. N., for the MUSTT Investigators, (2007). Limitations of Ejection Fraction for Prediction of Sudden Death Risk in Patients With Coronary Artery Disease: Lessons From the MUSTT Study. J Am Coll Cardiol 50: 1150-1157 [Abstract] [Full Text]  
• Almendral, J., Josephson, M. E. (2007). All Patients With Hemodynamically Tolerated Postinfarction Ventricular Tachycardia Do Not Require an Implantable Cardioverter-Defibrillator. Circulation 116: 1204-1212 [Full Text]  
• Faber, T. S., Gradinger, R., Treusch, S., Morkel, C., Brachmann, J., Bode, C., Zehender, M., for the EVENTS Investigators, (2007). Incidence of ventricular tachyarrhythmias during permanent pacemaker therapy in low-risk patients results from the German multicentre EVENTS study. Eur Heart J 28: 2238-2242 [Abstract] [Full Text]  
• Authors/Task Force Members, , Vardas, P. E., Auricchio, A., Blanc, J.-J., Daubert, J.-C., Drexler, H., Ector, H., Gasparini, M., Linde, C., Morgado, F. B., Oto, A., Sutton, R., Trusz-Gluza, M., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Funck-Brentano, C., Filippatos, G., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Priori, S. G., Blomstrom-Lundqvist, C., Brignole, M., Terradellas, J. B., Camm, J., Castellano, P., Cleland, J., Farre, J., Fromer, M., Le Heuzey, J.-Y., Lip, G. Y., Merino, J. L., Montenero, A. S., Ritter, P., Schalij, M. J., Stellbrink, C. (2007). Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Eur Heart J 28: 2256-2295 [Full Text]  
• England, R., England, T., Coggon, J. (2007). The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer. J. Med. Ethics 33: 538-540 [Abstract] [Full Text]